Microsaic Systems Appoints Colin Jump as New CEO
News Nov 06, 2012
With over 30 years of experience working in the analytical instrumentation sector, Colin has a proven track record helping companies to achieve significant growth and will bring a vast amount of commercial and operational acumen to the role.
Prior to joining Microsaic, Colin was responsible for developing and growing Shimadzu UK Ltd, a global manufacturer of scientific research instruments.
As UK Managing Director of Shimadzu UK Ltd for the past 11 years, Colin led the company using his extensive business experience and industry knowledge to implement comprehensive growth and marketing communication strategies, both of which will be invaluable in the development and growth of Microsaic Systems going forward.
Before managing Shimadzu UK Ltd, Colin was European Commercial Director at SGE Europe Ltd, which followed seven years in senior management and marketing positions at Mallinckrodt Baker in the UK and the Netherlands.
In addition, his prior roles in sales and marketing positions at Bayer Diagnostics, Boehringer Mannheim UK and Wellcome Diagnostics will undoubtedly be beneficial to Mircosaic Systems as it looks to establish its innovative chip-based scientific instruments within the analytical instrumentation market.
“Microsaic Systems is the first and only company to have commercialized MS (mass spectrometry) technology on a chip,” said Colin Jump.
“This places the company in an optimal position to deliver this gold standard technique for chemical analysis to a much wider range of users and applications.”
He continues, “I am excited to be joining Microsaic Systems at this crucial stage as it accelerates the commercialization of its revolutionary chip-based technology. With the ability to address major opportunities across multiple market areas I see huge potential for the technology and for the Company in the years ahead.”
“Our breakthrough product, the 3500 MiD, represents a step change in the ease of use and footprint of mass spectrometry. The instrument is smaller, lighter, consumes less energy, is easier to maintain and cheaper to run than conventional MS systems,” comments Eric Yeatman, Acting CEO of Microsaic Systems.
Yeatman continued, “The Board is very pleased to welcome Colin Jump to the company as our new CEO and I have no doubt his commercial and operational experience in the analytical instrumentation sector will help drive the business forward towards the further realization of our corporate goals.”
The 3500 MiD is the culmination of over a decade of research, bringing together two high tech fields - chemical analysis and silicon micro-engineering - to make possible a transformative capability in detection.
Its low operating cost and small footprint make the 3500 MiD deployable in a wide range of applications where mass spectrometry has not been able to reach - until now.
Colin Jump will take up his role on 5th November 2012, at which point Eric Yeatman and Colin Nicholl will resume their former roles as Chairman and Deputy Chairman, respectively.
Penn Medicine Biochemist Receives Major Award for Research on Epigenetic Protein Modifications via Mass SpecNews
Benjamin A.Garcia, PhD, an expert in quantitative proteomics and Presidential Professor of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, has been awarded the Biemann Medal by the American Society for Mass Spectrometry (ASMS). The early-career award recognizes significant achievement in basic or applied mass spectrometry.
The Friedrich Schiller University Jena Partners with ACD/Labs to Advance its Analytical Data Management StrategyNews
Implementation of ACD/Spectrus as an analytical data management system helps researchers and students streamline NMR and MS data processing, interpretation, collaboration, and training.READ MORE